Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 62/666,462, filed May 3, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 7,449,458 | Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses In force · High confidence | Rigel Pharmaceuticals, Inc. | In force | High confidence | ||
| US 10,822,337 | TGF-ß InhibitorC In force · High confidence | Rigel Pharmaceuticals, Inc. | In force | High confidence | ||
| US 12,227,508 | Tgf-ß Inhibitors In force · High confidence | Rigel Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,982,000 | Pyrazole Compounds and Method for Making and Using the Compounds In force · High confidence | Rigel Pharmaceuticals, Inc. | In force | High confidence | ||
| US 10,208,074 | Pyrazole Compounds and Method for Making and Using the Compounds In force · High confidence | Rigel Pharmaceuticals, Inc. | In force | High confidence | ||
| US 10,208,075 | Pyrazole Compounds and Method for Making and Using the Compounds In force · High confidence | Rigel Pharmaceuticals, Inc. | In force | High confidence | ||
| US 11,370,808 | Pyrazole Compounds and Methods for Making and Using the Compounds In force · High confidence | Rigel Pharmaceuticals, Inc. | In force | High confidence | ||
| US 10,030,005 | Inhibitors of Ret In force · High confidence | Rigel Pharmaceuticals, Inc. | In force | High confidence | ||
| US 10,584,114 | Inhibitors of Ret In force · High confidence | Rigel Pharmaceuticals, Inc. | In force | High confidence | ||
| US 11,279,688 | Inhibitors of Ret In force · High confidence | Rigel Pharmaceuticals, Inc. | In force | High confidence | ||
| 82 more patents in this group · Pro | ||||||
10 of 92 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 92, including 22 expired.
33 of these are in force and held by Rigel Pharmaceuticals, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.